Katalog Phytoplan 2004 Referenzsubstanzen

Total Page:16

File Type:pdf, Size:1020Kb

Katalog Phytoplan 2004 Referenzsubstanzen Version 1/2006 PHYTOPLAN® Pflanzliche Wirkstoffe und AnalytikI Product List 2006 Reference Substances Natural Compounds PHYTOPLAN Diehm & Neuberger GmbH Im Neuenheimer Feld 519 69120 Heidelberg Germany Phone: +49 62 21 / 40 13 47 Fax: +49 62 21 / 43 76 64 e-Mail: [email protected] Internet: www.Phytoplan.de PHYTOPLAN ® Dear customer, we are pleased to introduce our new catalogue for the year 2006. Therein you will find many new products and also a greater range in the qualities of the compounds differing in the degre of purity and the documents delivered. Please decide which item is the proper for your purpose. All substances are provided with a certificate of analysis of the batch delivered. This includs the analytical data shown in the second column 'documents' of the catalogue. The reference substances mostly have a purity greater than 99.0% determined by HPLC-DAD. Enclosed you will find a comprehensive documentation about the identity and purity determinations. All these compounds are provided with a certificate of analysis including HPLC-DAD, TLC, 1H-NMR, 13C-NMR, UV, IR, MS. Depending on the compound other determinations like elemental analysis, optical rotation, content of water have ben made. Larger quantities of order may cfrome a longer delivery period. All substances which are only delivered with a HPLC-Chromatogram can also be obtained as documented reference substance on demand. In this case we will send you an individual offer. If you ned one or more compounds not listed, even from a definite plant, we will proof the possibility of supply. The requirements for the documentation and specification will be suited to your request. The prices will be calculated by the concrete expenditure and will be offered on demand. For inquiry please contact: Mr. Dr. Michael Diehm or Mr. Dr. Karl Neuberger Phone: 0049 6221 401347 Fax: 0049 6221 437664 e-Mail: [email protected] Page 2 PHYTOPLAN ® Table of compounds Acetoxyvalerenic acid Echinacoside Isovitexin Acetylacteoside Elenolic acid glucoside Kaempferol Acetyl-α-boswellic acid Eleutheroside B Kaempferol-3-glucoside Acetyl-β-boswellic acid Eleutheroside E 11-Keto-β-boswellic acid Acetyl-11-keto-β-boswellic acid Emodin (Frangula-) Lutein Actein ( - )-Epicatechin Luteolin Acteoside ( - )-Epicatechingallat Luteolin-7-glucoside Agnuside ( - )-Epigallocatechin Lycopin Aloe-Emodin ( - )-Epigallocatechingallat Malvin chloride Aloenin A Frangulin (A + B) Naringenin Apigenin Frangulin A Naringin Apigenin-7-glucoside Frangulin B Oleuropein Apiin ( - )-Gallocatechin Orientin Aristolochic acid I/II mixture Gingerol-[6] Picroside II Aristolochic acid I/II sodium salt Gingerol-[8] Primin Aristolochic acid I Ginkgolide A Primulaverin Aristolochic acid II Ginkgolide B Primverin Aucubin Ginkgolide C Pseudohypericin Azadirachtin Glucotropaeolin Quercetin Baicalein Gossypin Quercitrin Baicalin Hamamelitannin Retrorsin Betulin Harpagide Rhein Betulinic acid Harpagoside Rosmarinic acid Bilobalide Hederacoside C Saponarin α-Boswellic acid Hederagenin Senecionine β-Boswellic acid α-Hederin Seneciphylline Caftaric acid Hesperetin Senkirkin Casticin Hesperidin Sennoside A Catalpol Homoorientin Sennoside B ( - )-Catechin Hydroxytyrosol Silybin ( + )-Catechin Hydroxyvalerenic acid Sinigrin Chelideonin Hyperforin Spiraeoside Cichoric acid acid Hypericin Taxifolin Coptisin Hypericin sodium salt Valerenic acid Curcumin Hyperoside Vitexin Cyanin chloride Isoacteoside Vitexin-2‘‘-O-rhamnoside Cynarin Isoquercitrin Xanthohumol 27-Deoxyactein Isorhamnetin Page 3 PHYTOPLAN ® Catalogue of Natural Compounds Compound documents quantity price delivered [Euro] O Acetoxyvalerenic acid HPLC-DAD (2 methods), 25 mg 280,- CH3 H3C O H from Valeriana officinalis TLC (2 methods), 1 13 100 mg 1.000,- Art. 4402.RS >99.0 % H-NMR, C-NMR - (with Interpretation), CH [81397-67-3] 3 CH3 UV, IR, MS C17H24O4 Mr 292.37 COOH 6-O-Acetylacteoside HPLC-DAD, TLC, 20 mg 210,- OAc O from Harpagophytum procumbens 1 13 HO O H-NMR, C-NMR O O OOH 50 mg 420,- HO OH - (with Interpretation), H3C O Art. 6100.RS >99.0 % HO OH HO UV, IR, MS, melting point HO [ - ] C31H38O17 Mr 666.64 6-O-Acetylacteoside HPLC-DAD with UV-spectrum 10 mg 110,- OAc O from Harpagophytum procumbens HO O O O OOH 20 mg 190,- HO OH H3C O Art. 6100.99 >99.0 % HO OH HO HO [ - ] 50 mg 380,- C31H38O17 Mr 666.64 H3C CH3 3-Acetyl-α-boswellic acid HPLC-DAD with UV-spectrum 5 mg 125,- H (3α,4β)-3-Acetoxy-olean-12-en-23-acid from Boswellia serrata 10 mg 200,- H3C CH3 CH3 H CH3 Art. 5154.99 >99.0 % 20 mg 340,- AcO H [ - ] HOOC CH 3 C32H50O4 Mr 498.73 3-Acetyl-β-boswellic acid CH3 HPLC-DAD with UV-spectrum 5mg 125,- H3C (3α,4β)-3α-Acetoxy-urs-12-en-23-acid H from Boswellia serrata 10 mg 200,- H3C CH3 CH3 Art. 5151.99 >99.0 % 20 mg 340,- H CH3 [5968-70-7] AcO H C32H50O4 Mr 498.73 HOOC CH3 CH3 3-Acetyl-11-keto- -boswellic acid 5mg 115,- H3C β HPLC-DAD with UV-spectrum H 3α-Acetoxy-urs-12-en-11-keto-23-acid O 10 mg 180,- H3C CH3 CH3 from Boswellia serrata H CH3 Art. 5153.99 >99.0 % 20 mg 305,- AcO H [67416-61-9] HOOC CH3 C32H48O5 Mr 512.73 Actein 10 mg 450,- H3C HPLC-DAD (2 methods), AcO O OH from Cimicifuga racemosa CH3 O TLC (2 methods), O 1 13 50 mg 2.000,- CH3 Art. 3506.RS >99.0 % H-NMR, C-NMR - (with Interpretation), CH3 [18642-44-9] Xyl-O IR, MS, hr-MS, melting point H3CCH3 C37H56O11 Mr 676.84 Actein 5 mg 220,- H3C HPLC-DAD with UV-spectrum AcO O OH from Cimicifuga racemosa CH3 O O 10 mg 400,- CH3 Art. 3506.99 >99.0 % CH3 [18642-44-9] 20 mg 690,- Xyl-O H3CCH3 C37H56O11 Mr 676.84 page 4 PHYTOPLAN ® Catalogue of Natural Compounds Compound documents quantity price delivered [Euro] Acteoside 20 mg 225,- OH HPLC-DAD, TLC, O HO O Verbascoside 1 13 O H-NMR, C-NMR O OOH 50 mg 450,- HO OH from Paulownia tormentosa - (with Interpretation), H3C O HO OH HO UV, IR, MS HO Art. 6101.RS >98.0 % [61276-17-3] C29H36O15 Mr 624.59 Acteoside 10 mg 120,- OH HPLC-DAD with UV-spectrum O HO O Verbascoside O O OOH 20 mg 200,- HO OH from Paulownia tormentosa H3C O HO OH HO HO Art. 6101.98 >98.0 % 50 mg 400,- [61276-17-3] C29H36O15 Mr 624.59 Agnuside 10 mg 150,- HO HO H HPLC-DAD with UV-spectrum 10-p-Hydroxybenzoylaucubin from Vitex agnus castus 20 mg 255,- O H Art. 2102.98 >98.0 % O CH2 O-Glu O [11027-63-7] C22H26O11 Mr 466.44 OHO OH Aloe-Emodin HPLC-DAD, TLC 20 mg 195,- 1,8-Dihydroxy-3-(hydroxymethyl)- 1H-NMR, 13C-NMR anthrachinon, synthetisch - (with Interpretation), 50 mg 390,- CH2OH UV, IR, MS, melting point O Art. 3714.RS >99.0 % [481-72-1] C15H10O5 Mr 270.23 OHO OH Aloe-Emodin HPLC-DAD with UV-spectrum 10 mg 100,- 1,8-Dihydroxy-3-(hydroxymethyl)- anthrachinon, synthetisch 20 mg 170,- CH2OH O Art. 3714.99 >99.0 % 50 mg 340,- [481-72-1] C15H10O5 Mr 270.23 HO OGlu Aloenin A HPLC-DAD with UV-spectrum 10 mg 130,- from Aloe arborescens O O 50 mg 500,- CH3 Art. 4105.99 >99.0 % [38412-46-3] OCH 3 C19H22O10 Mr 410.38 Apigenin OH HPLC-DAD, TLC 20 mg 140,- 4',5,7-Trihydroxyflavon 1H-NMR, 13C-NMR HO O from Chamomillae romana - (with Interpretation), 50 mg 280,- UV, IR, MS, melting point Art. 3205.RS >99.0 % 100 mg 485,- OH O [520-36-5] C15H10O5 Mr 270.23 Apigenin OH HPLC-DAD with UV-spectrum 20 mg 125,- 4',5,7-Trihydroxyflavon HO O from Chamomillae romana 50 mg 250,- Art. 3205.99 >99.0 % 100 mg 440,- OH O [520-36-5] C15H10O5 Mr 270.23 page 5 PHYTOPLAN ® Catalogue of Natural Compounds Compound documents quantity price delivered [Euro] Apigenin OH HPLC-DAD with UV-spectrum 50 mg 110,- 4',5,7-Trihydroxyflavon HO O from Chamomillae romana Art. 3205.97 >97.0 % OH O [520-36-5] C15H10O5 Mr 270.23 OH Apigenin-7-glucoside HPLC-DAD (2 methods) 10 mg 130,- Glu-O O Apigetrin, Cossmetin, 7-Glucosylapigenin TLC, 1H-NMR, 13C-NMR from Chamomillae romana - (with Interpretation), 20 mg 220,- UV, IR, MS, melting point OH O Art. 3207.RS >99.0 % 50 mg 440,- [578-74-5] 100 mg 690,- C21H20O10 Mr 432.38 OH Apigenin-7-glucoside HPLC-DAD with UV-spectrum 10 mg 110,- Glu-O O Apigetrin, Cossmetin, 7-Glucosylapigenin from Chamomillae romana 20 mg 190,- OH O Art. 3207.99 >99.0 % 50 mg 350,- [578-74-5] C21H20O10 Mr 432.38 OH Apigenin-7-glucoside HPLC-DAD with UV-spectrum 100 mg 100,- Glu-O O Apigetrin, Cossmetin, 7-Glucosylapigenin from Chamomillae romana OH O Art. 3207.97 >97.0 % [578-74-5] C21H20O10 Mr 432.38 OH Apiin HPLC-DAD (2 methods), 10 mg 200,- Apioside, Apigenin-7-apiosylglucoside TLC (2 methods), Api-Glu-O O 20 mg 340,- from Petroselinum crispum 1H-NMR, 13C-NMR - (with Interpretation), Art. 3244.RS >98.0 % OH O UV, IR, MS, melting point [26544-34-3] C26H28O14 Mr 564.50 OH Apiin HPLC-DAD with UV-spectrum 10 mg 150,- Apioside, Apigenin-7-apiosylglucoside Api-Glu-O O from Petroselinum crispum 20 mg 255,- OH O Art. 3244.98 >98.0 % [26544-34-3] C26H28O14 Mr 564.50 O COOH Aristolochic acid HPLC-DAD with UV-spectrum 500 mg 135,- mixture from I und II O NO2 from Aristolochia clematitis Art. 4610.96 >96.0 % R [67123-64-2] O COOHNa Aristolochic acid sodium salt HPLC-DAD with UV-spectrum 250 mg 145,- O NO2 mixture from I und II sodium salt 500 mg 255,- from Aristolochia clematitis Art.
Recommended publications
  • Flavonoid Application in Treatment of Oral Cancer-A Review
    European Journal of Molecular & Clinical Medicine ISSN 2515-8260 Volume 07, Issue 01, 2020 FLAVONOID APPLICATION IN TREATMENT OF ORAL CANCER-A REVIEW Sudarsan R1, Lakshmi T2, Anjaneyulu K3 1Undergraduate student, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 77 2Associate Professor, Department of Pharmacology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 77 3 Reader, Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 77 ABSTRACT A wide range of organic compounds that are naturally occurring called flavonoids are primarily found in a large variety of plants. Some of the sources include tea, wine, fruits, grains, nuts and vegetables. There are a number of studies that have proven that a strong association exists between intake of dietary flavonoid and its effects on mortality in the long run. Flavonoids at non-toxic concentrations are known to demonstrate a wide range of therapeutic biological activities in organisms. The contribution of flavonoids in prevention of cancer is an area of great interest in current research. A variety of studies, including in vitro experiments and human trials and even epidemiological investigations, provide compelling evidence which imply that flavonoids’ effects on cancer in terms of chemoprevention and chemotherapy is significant. As the current treatment methods possess a number of drawbacks, the anticancer potential demonstrated by flavonoids makes them a reliable alternative. Various studies have focussed on flavonoids’ anti-cancer potential and its possible application in the treatment of cancer as a chemopreventive agent.
    [Show full text]
  • Effects of Enzymatic and Thermal Processing on Flavones, the Effects of Flavones on Inflammatory Mediators in Vitro, and the Absorption of Flavones in Vivo
    Effects of enzymatic and thermal processing on flavones, the effects of flavones on inflammatory mediators in vitro, and the absorption of flavones in vivo DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Gregory Louis Hostetler Graduate Program in Food Science and Technology The Ohio State University 2011 Dissertation Committee: Steven Schwartz, Advisor Andrea Doseff Erich Grotewold Sheryl Barringer Copyrighted by Gregory Louis Hostetler 2011 Abstract Flavones are abundant in parsley and celery and possess unique anti-inflammatory properties in vitro and in animal models. However, their bioavailability and bioactivity depend in part on the conjugation of sugars and other functional groups to the flavone core. Two studies were conducted to determine the effects of processing on stability and profiles of flavones in celery and parsley, and a third explored the effects of deglycosylation on the anti-inflammatory activity of flavones in vitro and their absorption in vivo. In the first processing study, celery leaves were combined with β-glucosidase-rich food ingredients (almond, flax seed, or chickpea flour) to determine test for enzymatic hydrolysis of flavone apiosylglucosides. Although all of the enzyme-rich ingredients could convert apigenin glucoside to aglycone, none had an effect on apigenin apiosylglucoside. Thermal stability of flavones from celery was also tested by isolating them and heating at 100 °C for up to 5 hours in pH 3, 5, or 7 buffer. Apigenin glucoside was most stable of the flavones tested, with minimal degradation regardless of pH or heating time.
    [Show full text]
  • Identification of Apigenin and Luteolin in Artemisia Annua L. for the Quality
    Phadungrakwittaya et al. Identification of Apigenin and Luteolin inArtemisia annua L. for the Quality Control Rattana Phadungrakwittaya*, Sirikul Chotewuttakorn*, Manoon Piwtong**, Onusa Thamsermsang**, Tawee Laohapand**, Pravit Akarasereenont*,** *Department of Pharmacology, **Center of Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. ABSTRACT Objective: To identify active compounds and establish the chemical fingerprint ofArtemisia annua L. for the quality control. Methods: Thin-layer chromatography (TLC) conditions were developed to screen for 2 common flavonoids (apigenin and luteolin). Three mobile phases were used to isolate these flavonoids in 80% ethanolic extract of A. annua. Hexane : ethyl acetate : acetic acid (31:14:5, v/v) and toluene : 1,4-dioxane : acetic acid (90:25:4, v/v) were used in normal phase TLC (NP-TLC), and 5.5% formic acid in water : methanol (50:50, v/v) were used in reverse phase TLC (RP-TLC). Chromatograms were visualized under visible light after spraying with Fast Blue B Salt. Apigenin and luteolin bands were checked by comparing their Rf values and UV-Vis absorption spectra with reference markers. Results: Apigenin and luteolin were simultaneously detected with good specificity in RP-TLC condition, while only apigenin was detected in NP-TLC condition. Apigenin band intensity was higher than luteolin band intensity in both conditions. Conclusion: This knowledge can be applied to the development of quality control assessments to ensure product efficacy and consistency. Keywords: Artemisia annua L.; TLC fingerprint; apigenin; luteolin (Siriraj Med J 2019;71: 240-245) INTRODUCTION Thai herbal recipes that are published in The National Artemisia annua L., commonly known as sweet List of Essential Medicines.2 Several previous studies wormwood, is an annual plant in the Asteraceae (Compositae) reported that A.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times
    Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times Each volume in this series provides academia, health sciences, and the herbal medicines industry with in-depth coverage of the herbal remedies for infectious diseases, certain medical conditions, or the plant medicines of a particular country. Series Editor: Dr. Roland Hardman Volume 1 Shengmai San, edited by Kam-Ming Ko Volume 2 Rasayana: Ayurvedic Herbs for Rejuvenation and Longevity, by H.S. Puri Volume 3 Sho-Saiko-To: (Xiao-Chai-Hu-Tang) Scientific Evaluation and Clinical Applications, by Yukio Ogihara and Masaki Aburada Volume 4 Traditional Medicinal Plants and Malaria, edited by Merlin Willcox, Gerard Bodeker, and Philippe Rasoanaivo Volume 5 Juzen-taiho-to (Shi-Quan-Da-Bu-Tang): Scientific Evaluation and Clinical Applications, edited by Haruki Yamada and Ikuo Saiki Volume 6 Traditional Medicines for Modern Times: Antidiabetic Plants, edited by Amala Soumyanath Volume 7 Bupleurum Species: Scientific Evaluation and Clinical Applications, edited by Sheng-Li Pan Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Bruno Burlando, Luisella Verotta, Laura Cornara, and Elisa Bottini-Massa Cover art design by Carlo Del Vecchio. CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-1-4398-1214-3 (Ebook-PDF) This book contains information obtained from authentic and highly regarded sources.
    [Show full text]
  • Download PDF Flyer
    REVIEWS IN PHARMACEUTICAL & BIOMEDICAL ANALYSIS Editors: Constantinos K. Zacharis and Paraskevas D. Tzanavaras eBooks End User License Agreement Please read this license agreement carefully before using this eBook. Your use of this eBook/chapter constitutes your agreement to the terms and conditions set forth in this License Agreement. Bentham Science Publishers agrees to grant the user of this eBook/chapter, a non-exclusive, nontransferable license to download and use this eBook/chapter under the following terms and conditions: 1. This eBook/chapter may be downloaded and used by one user on one computer. The user may make one back-up copy of this publication to avoid losing it. The user may not give copies of this publication to others, or make it available for others to copy or download. For a multi-user license contact [email protected] 2. All rights reserved: All content in this publication is copyrighted and Bentham Science Publishers own the copyright. You may not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit any of this publication’s content, in any form by any means, in whole or in part, without the prior written permission from Bentham Science Publishers. 3. The user may print one or more copies/pages of this eBook/chapter for their personal use. The user may not print pages from this eBook/chapter or the entire printed eBook/chapter for general distribution, for promotion, for creating new works, or for resale. Specific permission must be obtained from the publisher for such requirements.
    [Show full text]
  • Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MA
    Int. J. Biol. Sci. 2016, Vol. 12 72 Ivyspring International Publisher International Journal of Biological Sciences 2016; 12(1): 72-86. doi: 10.7150/ijbs.13188 Research Paper Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways Hongming Lv1#, Zhenxiang Yu2#, Yuwei Zheng1, Lidong Wang1, Xiaofeng Qin1, Genhong Cheng1, Xinxin Ci1 1. Institute of Translational Medicine, The First Hospital of Jilin University, College of Veterinary Medicine, Jilin University, Changchun, China 2. Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, China. # These authors contributed equally to this work. Corresponding author: X.-X.Ci, Institute of Translational Medicine, The First Hospital, Jilin University, Changchun, 130001, China. Tel.: +86 431 88783044; E-mail addresses: [email protected] (X.-X.Ci.) © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. Received: 2015.07.08; Accepted: 2015.11.02; Published: 2016.01.01 Abstract Oxidative damage and inflammation are closely associated with the pathogenesis of acute lung injury (ALI). Thus, we explored the protective effect of isovitexin (IV), a glycosylflavonoid, in the context of ALI. To accomplish this, we created in vitro and in vivo models by respectively exposing macrophages to lipopolysaccharide (LPS) and using LPS to induce ALI in mice. In vitro, our results showed that IV treatment reduced LPS-induced pro-inflammatory cytokine secretion, iNOS and COX-2 expression and decreased the generation of ROS.
    [Show full text]
  • Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
    Review Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin Rashida Ginwala, Raina Bhavsar, DeGaulle I. Chigbu, Pooja Jain and Zafar K. Khan * Department of Microbiology and Immunology, and Center for Molecular Virology and Neuroimmunology, Center for Cancer Biology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19129, USA; [email protected] (R.G.); [email protected] (R.B.); [email protected] (D.I.C.); [email protected] (P.J.) * Correspondence: [email protected] Received: 28 November 2018; Accepted: 30 January 2019; Published: 5 February 2019 Abstract: Inflammation has been reported to be intimately linked to the development or worsening of several non-infectious diseases. A number of chronic conditions such as cancer, diabetes, cardiovascular disorders, autoimmune diseases, and neurodegenerative disorders emerge as a result of tissue injury and genomic changes induced by constant low-grade inflammation in and around the affected tissue or organ. The existing therapies for most of these chronic conditions sometimes leave more debilitating effects than the disease itself, warranting the advent of safer, less toxic, and more cost-effective therapeutic alternatives for the patients. For centuries, flavonoids and their preparations have been used to treat various human illnesses, and their continual use has persevered throughout the ages. This review focuses on the anti-inflammatory actions of flavonoids against chronic illnesses such as cancer, diabetes, cardiovascular diseases, and neuroinflammation with a special focus on apigenin, a relatively less toxic and non-mutagenic flavonoid with remarkable pharmacodynamics. Additionally, inflammation in the central nervous system (CNS) due to diseases such as multiple sclerosis (MS) gives ready access to circulating lymphocytes, monocytes/macrophages, and dendritic cells (DCs), causing edema, further inflammation, and demyelination.
    [Show full text]
  • Antineoplastic Potential of the Vitex Species: an Overview
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas BOLETÍN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMÁTICAS 17 (5): 492 - 502 (2018) © / ISSN 0717 7917 / www.blacpma.usach.cl Revisión | Review Antineoplastic potential of the Vitex species: An overview [Potencial antineoplásico de la especie Vitex: una visión general] Manisha Nigam1, Sarla Saklani2, Sergey Plygun3,4 & Abhay Prakash Mishra2 1Department of Biochemistry, H. N. B. Garhwal (A Central) University, Srinagar Garhwal, 246174, Uttarakhand, India 2Department of Pharmaceutical Chemistry, H. N. B. Garhwal (A Central) University, Srinagar Garhwal, 246174, Uttarakhand, India 3All Russian Research Institute of Phytopathology, Moscow Region, Russia 4European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland Contactos | Contacts: Abhay Prakash MISHRA - E-mail address: [email protected] Abstract: Irrespective of progressive treatments, cancer remains to have the utmost rate of treatment failure due to numerous reasons associated. In recent years, the use of traditional medicine in cancer research has established considerable interest. Natural products represent an amazing source for cancer therapy and combating associated side-effects. More than thousand plants have been found to possess significant anticancer properties. Vitex is the largest genus in the family Lamiaceae which comprises 250 species distributed throughout world and several species have been reported to have anticancer properties. Despite a long tradition of use of some species, the genus has not been explored properly in terms of its anticancer profile. Here we are reporting the updated knowledge of the antineoplastic profile of this genus available so far.
    [Show full text]
  • WO 2011/086458 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . ... _ 21 July 2011 (21.07.2011) WO 2011/086458 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61L 27/20 (2006.01) A61L 27/54 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/IB20 11/000052 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 13 January 201 1 (13.01 .201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (26) Publication Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 12/687,048 13 January 2010 (13.01 .2010) US (84) Designated States (unless otherwise indicated, for every 12/714,377 26 February 2010 (26.02.2010) US kind of regional protection available): ARIPO (BW, GH, 12/956,542 30 November 2010 (30.1 1.2010) us GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, (71) Applicant (for all designated States except US): AL- TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, LERGAN INDUSTRIE, SAS [FR/FR]; Route de EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Promery, Zone Artisanale de Pre-Mairy, F-74370 Pringy LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (FR).
    [Show full text]
  • Bioavailability of Apigenin from Apiin-Rich Parsley in Humans
    Original Paper Ann Nutr Metab 2006;50:167–172 Received: January 31, 2005 Accepted: September 8, 2005 DOI: 10.1159/000090736 Published online: January 10, 2006 Bioavailability of Apigenin from Apiin-Rich Parsley in Humans a a b a,c Hellen Meyer Adrian Bolarinwa Guenther Wolfram Jakob Linseisen a b Unit of Human Nutrition and Cancer Prevention and Department of Food and Nutrition, c Technical University of Munich, Freising-Weihenstephan , and Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg , Germany Key Words Introduction Apigenin Apigenin-free diet Apigenin, humans Apigenin, absorption Apiin Luteolin-free diet Flavonoids are abundant phenolic plant substances Parsley that can be divided into six subclasses which all share the common phenylchromane structure consisting of two ar- omatic rings (A and B) and an oxygenated heterocyclic Abstract ring (C) [1] . Apigenin (5,7,4 -trihydroxyfl avone) belongs Aim: Absorption and excretion of apigenin after the in- to the subclass of fl avones and is present in very low gestion of apiin-rich food, i.e. parsley, was tested. Meth- amounts in the human diet [2] . Thus, apigenin has not ods: Eleven healthy subjects (5 women, 6 men) in the age been examined well for aspects like bioavailability distri- range of 23–41 years and with an average body mass bution or excretion in humans. Important food sources index of 23.9 8 4.1 kg/m 2 took part in this study. After an of apigenin as identifi ed to date are parsley and celery [3]. apigenin- and luteolin-free diet, a single oral bolus of Only few studies gave indication on the average dietary 2 g blanched parsley (corresponding to 65.8 8 15.5 mol intake.
    [Show full text]
  • Flavonoids from Artemisia Annua L. As Antioxidants and Their Potential Synergism with Artemisinin Against Malaria and Cancer
    Molecules 2010, 15, 3135-3170; doi:10.3390/molecules15053135 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer 1, 2 3 4 Jorge F.S. Ferreira *, Devanand L. Luthria , Tomikazu Sasaki and Arne Heyerick 1 USDA-ARS, Appalachian Farming Systems Research Center, 1224 Airport Rd., Beaver, WV 25813, USA 2 USDA-ARS, Food Composition and Methods Development Lab, 10300 Baltimore Ave,. Bldg 161 BARC-East, Beltsville, MD 20705-2350, USA; E-Mail: [email protected] (D.L.L.) 3 Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA; E-Mail: [email protected] (T.S.) 4 Laboratory of Pharmacognosy and Phytochemistry, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium; E-Mail: [email protected] (A.H.) * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 26 January 2010; in revised form: 8 April 2010 / Accepted: 19 April 2010 / Published: 29 April 2010 Abstract: Artemisia annua is currently the only commercial source of the sesquiterpene lactone artemisinin. Since artemisinin was discovered as the active component of A. annua in early 1970s, hundreds of papers have focused on the anti-parasitic effects of artemisinin and its semi-synthetic analogs dihydroartemisinin, artemether, arteether, and artesunate. Artemisinin per se has not been used in mainstream clinical practice due to its poor bioavailability when compared to its analogs. In the past decade, the work with artemisinin-based compounds has expanded to their anti-cancer properties.
    [Show full text]